Chief Scientific Officer, Dr. Nathan Bryson and CEO, Joseph Del Moral
  • Field Trip’s CEO, Joseph Del Moral, and Chief Scientific Officer, Dr. Nathan Bryson will be participating in several investor conferences this month
  • Field Trip’s CEO and CSO will participate in a Fireside Chat at the H.C. Wainwright Global Investment Conference
  • They will also present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
  • Joseph Del Moral and Dr. Bryson will participate in Maxim Group’s Advances in Mental Health Conference
  • Ronan Levy, and  Dr. Nathan Bryson, will present at the Cantor Virtual Global Health Conference
  • Field Trip is a global leader in the development and delivery of psychedelic therapies
  • Field Trip Health Ltd. (FTRP) opened trading at C$6.58 per share

Field Trip Health (FTRP) is participating in several investor conferences in September.

The company will be presenting at the H.C. Wainwright Global Investment Conference, the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit, the Maxim Group Mental Health Conference and the Cantor Virtual Global Health Conference.

  • H.C. Wainwright Global Investment Conference (September 13) -Field Trip’s Co-founder and CEO, Joseph Del Moral, and Field Trip’s Chief Scientific Officer, Dr. Nathan Bryson, will participate in a Fireside Chat at the H.C. Wainwright Global Investment Conference. The Fireside Chat will be pre-recorded and will be accessible to those registered for the conference from Monday, September 13 at 7:00 am Eastern Time through Wednesday, September 15.
  • Oppenheimer Fall Healthcare Life Sciences and MedTech Summit (September 21) – Joseph Del Moral and Dr. Bryson will present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit at 2:55 pm Eastern Time on Tuesday, September 21. A recording of the presentation will be accessible on the Field Trip website.
  • Maxim Group’s Advances in Mental Health Conference (September 22) – Joseph Del Moral and Dr. Bryson will participate in Maxim Group’s Advances in Mental Health Conference, which will be held virtually on Wednesday, September 22. As part of the “Disruptors in the Mental Health Space” virtual panel series, Field Trip will participate in the Next-Gen Novel Chemical Entities and the Clinics and Commercialization panels.
  • Cantor Virtual Global Health Conference (September 29) – Ronan Levy, and  Dr. Nathan Bryson, will present at the Cantor Virtual Global Health Conference at 9:20 am Eastern Time on Wednesday, September 29. A recording of the presentation will be accessible on the Field Trip website for 180 days in the Investor Relations section under Events and Presentations.

Field Trip is a global leader in the development and delivery of psychedelic therapies.

Field Trip Health Ltd. (FTRP) opened trading at C$6.58 per share.

More From The Market Online

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.

PharmaDrug-PharmaTher Holdings JV submits clinical, regulatory package

Sairiyo Therapeutics, a PharmaDrug (CSE:PHRX) and PharmaTher Holdings (CSE:PHRM) joint venture, pursues a human clinical study in Australia.